{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:14:10Z","timestamp":1767831250350,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"MSD Belgium"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To characterize the frequency of PsA subtypes, estimate the severity based on damage and inflammation and estimate the impact of PsA on patients\u2019 health-related quality of life.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a longitudinal observational study in 17 academic and non-academic centres in Belgium. Patients with PsA fulfilling Classification Criteria for Psoriatic Arthritis were recruited. Three visits were scheduled: at baseline (T0), at 1\u2009year (\u00b11\u2009month; T1) and at 2\u2009years (\u00b11\u2009month; T2) of follow-up. Demographics, clinical data and patient-reported outcome measures were collected at T0, T1 and T2. X-rays of the hands and feet were collected yearly (T0, T1 and T2). X-rays of the spine were collected at T0 and T2. Here we report on the burden of disease based on the clinical data and patient-reported outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 461 patients were recruited; 73.5% had combined peripheral and axial involvement and 13.7% had hip involvement. Plaque psoriasis was predominant (83.9%). At inclusion, 42.7% and 58.8% had no tender or swollen joints, respectively. Dactylitis and enthesitis were still present in 13.7% and 24.1% of the patients, respectively. Patients was treated with DMARDs (68%) and\/or anti-TNF (44.2%). Forty-three per cent of the patients had a state of minimal disease activity and 62% considered the actual state as satisfactory. The mean HAQ score was 0.7%, with 32.5% of patients having a normal score (&amp;lt;0.3).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite the availability of different treatment options, including biologics (anti-TNF), a substantial number of patients have active disease and have a high disease burden.<\/jats:p><\/jats:sec>","DOI":"10.1093\/rheumatology\/keab233","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T20:13:26Z","timestamp":1615234406000},"page":"5677-5685","source":"Crossref","is-referenced-by-count":14,"title":["The burden of psoriatic arthritis in the biologics era: data from the Belgian Epidemiological Psoriatic Arthritis Study"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3848-5122","authenticated-orcid":false,"given":"Kurt","family":"de Vlam","sequence":"first","affiliation":[{"name":"Department of Rheumatology UZ Leuven and Skeletal Biology and Engineering Research Center"},{"name":"Department Development and Regeneration, KU Leuven, Leuven"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Steinfeld","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Hopit\u00e2l St Jean"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien Nzeusseu","family":"Toukap","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, IREC, UCLouvain and Cliniques Universitaires St. Luc, Brussels"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"van den Bosch","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, UZ Gent, Gent"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Joos","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, ZNA, Antwerp"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet","family":"Geysens","sequence":"additional","affiliation":[{"name":"ReumaClinic, Genk"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermine","family":"Leroi","sequence":"additional","affiliation":[{"name":"MSD, Medical Affairs, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik","family":"Lories","sequence":"additional","affiliation":[{"name":"Department of Rheumatology UZ Leuven and Skeletal Biology and Engineering Research Center"},{"name":"Department Development and Regeneration, KU Leuven, Leuven"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"2021121823180792000_keab233-B1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1056\/NEJMra1505557","article-title":"Psoriatic arthritis","volume":"376","author":"Ritchlin","year":"2017","journal-title":"N Engl J Med"},{"key":"2021121823180792000_keab233-B2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00296-017-3895-y","article-title":"Addressing comorbidities in psoriatic disease","volume":"38","author":"Patel","year":"2018","journal-title":"Rheumatol Int"},{"key":"2021121823180792000_keab233-B3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021121823180792000_keab233-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823180792000_keab233-B5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/rheumatology\/33.2.133","article-title":"Classification of clinical subsets in psoriatic arthritis","volume":"33","author":"Veale","year":"1994","journal-title":"Br J Rheumatol"},{"key":"2021121823180792000_keab233-B6","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/S0140-6736(18)30949-8","article-title":"Clinical management of psoriatic arthritis","volume":"391","author":"Van den Bosch","year":"2018","journal-title":"Lancet"},{"key":"2021121823180792000_keab233-B7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","article-title":"Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis","volume":"68","author":"Coates","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021121823180792000_keab233-B8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/BOR.0000000000000152","article-title":"Recognizing and managing comordibities in psoriatic arthritis","volume":"27","author":"Ogdie","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"2021121823180792000_keab233-B9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0950-3579(94)80024-3","article-title":"Natural history of psoriatic arthritis","volume":"8","author":"Gladman","year":"1994","journal-title":"Baillieres Clin Rheumatol"},{"key":"2021121823180792000_keab233-B10","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021121823180792000_keab233-B11","first-page":"323","article-title":"Psoriasis and arthritis","volume":"46","author":"Cats","year":"1990","journal-title":"Cutis"},{"key":"2021121823180792000_keab233-B12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1136\/ard.20.2.123","article-title":"Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis","volume":"20","author":"Wright","year":"1961","journal-title":"Ann Rheum Dis"},{"key":"2021121823180792000_keab233-B13","first-page":"680","article-title":"The burden of psoriatic arthritis: a literature review from a global health systems perspective","volume":"35","author":"Lee","year":"2010","journal-title":"P T"},{"key":"2021121823180792000_keab233-B14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","article-title":"The psychosocial burden of psoriatic arthritis","volume":"47","author":"Husni","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"2021121823180792000_keab233-B15","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/rheumatology\/keg445","article-title":"A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis\u2014\u2018DIP or not DIP revisited\u2019","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"2021121823180792000_keab233-B16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","article-title":"Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study","volume":"42","author":"McHugh","year":"2003","journal-title":"Rheumatology (Oxford"},{"key":"2021121823180792000_keab233-B17","first-page":"S36","article-title":"The enthesis in psoriatic arthritis","volume":"33","author":"McGonagle","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2021121823180792000_keab233-B18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3899\/jrheum.130163","article-title":"Dactylitis in psoriatic arthritis: prevalence and response to therapy in the biologic era","volume":"40","author":"Gladman","year":"2013","journal-title":"J Rheumatol"},{"key":"2021121823180792000_keab233-B19","first-page":"974","article-title":"Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis","volume":"32","author":"Taylor","year":"2005","journal-title":"J Rheumatol"},{"key":"2021121823180792000_keab233-B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/ard.57.3.135","article-title":"Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis?","volume":"57","author":"Helliwell","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"2021121823180792000_keab233-B21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.rdc.2015.07.001","article-title":"The epidemiology of psoriatic arthritis","volume":"41","author":"Ogdie","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2021121823180792000_keab233-B22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3899\/jrheum.180267","article-title":"What should be the primary target of \u201ctreat to target\u201d in psoriatic arthritis?","volume":"46","author":"Coates","year":"2019","journal-title":"J Rheumatol"},{"key":"2021121823180792000_keab233-B23","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1016\/S0140-6736(15)00347-5","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial","volume":"386","author":"Coates","year":"2015","journal-title":"Lancet"},{"key":"2021121823180792000_keab233-B24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/annrheumdis-2013-204858","article-title":"Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis","volume":"74","author":"Haroon","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2021121823180792000_keab233-B25","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3899\/jrheum.141359","article-title":"Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study","volume":"43","author":"Haque","year":"2016","journal-title":"J Rheumatol"},{"key":"2021121823180792000_keab233-B26","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/imj.14046","article-title":"Comorbidity in psoriatic arthritis and rheumatoid arthritis","volume":"48","author":"Sinnathurai","year":"2018","journal-title":"Intern Med J"},{"key":"2021121823180792000_keab233-B27","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s10067-019-04663-6","article-title":"Psoriatic arthritis and obesity: the role of anti-IL-12\/IL-23 treatment","volume":"38","author":"Costa","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2021121823180792000_keab233-B28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.20048","article-title":"Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population","volume":"50","author":"Eswar Krishnan","year":"2004","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab233\/37803145\/keab233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5677\/41820330\/keab233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/12\/5677\/41820330\/keab233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T18:31:11Z","timestamp":1697999471000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/12\/5677\/6169012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,3,12]]},"published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab233","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,3,12]]}}}